| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 165,321 | 165,942 | 164,099 | 170,489 | | Cost of Revenue | 129,725 | 124,835 | 130,255 | 135,987 | | | Gross Profit | 35,596 | 41,107 | 33,844 | 34,502 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,152 | 20,378 | 20,323 | 21,561 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,444 | 20,729 | 13,521 | 12,941 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38 | 33 | 3 | 57 | | Earnings Before Interest And Taxes | 14,482 | 20,762 | 13,524 | 12,998 | | Interest Expense | 177 | 196 | 262 | 472 | | Income Before Tax | 14,305 | 20,566 | 13,262 | 12,526 | | Income Tax Expense | 4,463 | 7,219 | 4,655 | 4,397 | | Minority Interest | 32 | (209) | 245 | (276) | | | | Net Income From Continuing Ops | 9,874 | 13,138 | 8,852 | 7,853 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,874 | 13,138 | 8,852 | 7,853 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,874 | $13,138 | $8,852 | $7,853 |
|
0.03% Nasdaq 
Income Statement
